Skip to content
healthcare.dev

Anubis Barcelona

NDC 83021-839, Propanediol, Glycerin, Magnesium Ascorbyl Phosphate, concentrate, from ANUBIS COSMETICS SL.

Product NDC
83021-839
Status
Listed
Labeler
ANUBIS COSMETICS SL
Dosage form
CONCENTRATE
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH FINAL
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83021-839 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCERIN.01035 g/1.5mL
  • PHENOXYETHANOL.0003 g/1.5mL
  • FRAGRANCE 13576.00285 g/1.5mL
  • DEHYDROACETIC ACID.00135 g/1.5mL
  • WATER1.16659425 mL/1.5mL
  • PEG-8 CAPRYLIC/CAPRIC GLYCERIDES.15 g/1.5mL
  • ISOMETHYL-.ALPHA.-IONONE.00003 g/1.5mL
  • EDETIC ACID.000009 g/1.5mL
  • BENZOIC ACID.0009 g/1.5mL
  • SORBIC ACID.0006 g/1.5mL
  • BENZYL ALCOHOL.01215 g/1.5mL
  • PROPANEDIOL.15 g/1.5mL
  • HYDROXYCITRONELLAL.00006 g/1.5mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Ammonium Ion Binding Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Decreased Coagulation Factor Activity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Lead Chelating Activity [MoA]; Lead Chelator [EPC]; Nitrogen Binding Agent [EPC]; Non-Standardized Chemical Allergen [EPC]; Pediculicide [EPC]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
83021-839-07830210839071.5 mL in 1 VIAL, SINGLE-USE (83021-839-07)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83021-839 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83021-839 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83021-839. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.